Cargando…
Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer
SIMPLE SUMMARY: Currently, the optimal treatment for colorectal cancer (CRC) is planned on the basis of the results of preoperative imaging studies. Previous studies investigating the impact of radiomics signatures derived from positron-emission tomography (PET) images mainly focused on patients wit...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866240/ https://www.ncbi.nlm.nih.gov/pubmed/33494345 http://dx.doi.org/10.3390/cancers13030392 |
_version_ | 1783648035589324800 |
---|---|
author | Kang, Jeonghyun Lee, Jae-Hoon Lee, Hye Sun Cho, Eun-Suk Park, Eun Jung Baik, Seung Hyuk Lee, Kang Young Park, Chihyun Yeu, Yunku Clemenceau, Jean R. Park, Sunho Xu, Hongming Hong, Changjin Hwang, Tae Hyun |
author_facet | Kang, Jeonghyun Lee, Jae-Hoon Lee, Hye Sun Cho, Eun-Suk Park, Eun Jung Baik, Seung Hyuk Lee, Kang Young Park, Chihyun Yeu, Yunku Clemenceau, Jean R. Park, Sunho Xu, Hongming Hong, Changjin Hwang, Tae Hyun |
author_sort | Kang, Jeonghyun |
collection | PubMed |
description | SIMPLE SUMMARY: Currently, the optimal treatment for colorectal cancer (CRC) is planned on the basis of the results of preoperative imaging studies. Previous studies investigating the impact of radiomics signatures derived from positron-emission tomography (PET) images mainly focused on patients with rectal cancer, who underwent preoperative chemoradiotherapy, and included a relatively small number of patients, without a validation set. The impact of PET-based radiomics signature analysis in patients undergoing curative-intent radical surgery, with or without chemotherapy, has not been extensively investigated. Thus, we aimed to identify the prognostic value of radiomics signature from(18)F-fluorodeoxyglucose ((18)F-FDG) PET images by assessing the imaging features to predict the progression-free survival in patients with CRC. This study demonstrated that radiomics features derived from PET-CT images can help stratify patient prognosis and additionally increase diagnostic accuracy with respect to conventional clinicopathological data-driven prediction model in patients with CRC. ABSTRACT: The aim of this study was to investigate the prognostic value of radiomics signatures derived from (18)F-fluorodeoxyglucose ((18)F-FDG) positron-emission tomography (PET) in patients with colorectal cancer (CRC). From April 2008 to Jan 2014, we identified CRC patients who underwent (18)F-FDG-PET before starting any neoadjuvant treatments and surgery. Radiomics features were extracted from the primary lesions identified on (18)F-FDG-PET. Patients were divided into a training and validation set by random sampling. A least absolute shrinkage and selection operator Cox regression model was applied for prognostic signature building with progression-free survival (PFS) using the training set. Using the calculated radiomics score, a nomogram was developed, and its clinical utility was assessed in the validation set. A total of 381 patients with surgically resected CRC patients (training set: 228 vs. validation set: 153) were included. In the training set, a radiomics signature labeled as a rad_score was generated using two PET-derived features, such as gray-level run length matrix long-run emphasis (GLRLM_LRE) and gray-level zone length matrix short-zone low-gray-level emphasis (GLZLM_SZLGE). Patients with a high rad_score in the training and validation set had a shorter PFS. Multivariable analysis revealed that the rad_score was an independent prognostic factor in both training and validation sets. A radiomics nomogram, developed using rad_score, nodal stage, and lymphovascular invasion, showed good performance in the calibration curve and comparable predictive power with the staging system in the validation set. Textural features derived from (18)F-FDG-PET images may enable detailed stratification of prognosis in patients with CRC. |
format | Online Article Text |
id | pubmed-7866240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78662402021-02-07 Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer Kang, Jeonghyun Lee, Jae-Hoon Lee, Hye Sun Cho, Eun-Suk Park, Eun Jung Baik, Seung Hyuk Lee, Kang Young Park, Chihyun Yeu, Yunku Clemenceau, Jean R. Park, Sunho Xu, Hongming Hong, Changjin Hwang, Tae Hyun Cancers (Basel) Article SIMPLE SUMMARY: Currently, the optimal treatment for colorectal cancer (CRC) is planned on the basis of the results of preoperative imaging studies. Previous studies investigating the impact of radiomics signatures derived from positron-emission tomography (PET) images mainly focused on patients with rectal cancer, who underwent preoperative chemoradiotherapy, and included a relatively small number of patients, without a validation set. The impact of PET-based radiomics signature analysis in patients undergoing curative-intent radical surgery, with or without chemotherapy, has not been extensively investigated. Thus, we aimed to identify the prognostic value of radiomics signature from(18)F-fluorodeoxyglucose ((18)F-FDG) PET images by assessing the imaging features to predict the progression-free survival in patients with CRC. This study demonstrated that radiomics features derived from PET-CT images can help stratify patient prognosis and additionally increase diagnostic accuracy with respect to conventional clinicopathological data-driven prediction model in patients with CRC. ABSTRACT: The aim of this study was to investigate the prognostic value of radiomics signatures derived from (18)F-fluorodeoxyglucose ((18)F-FDG) positron-emission tomography (PET) in patients with colorectal cancer (CRC). From April 2008 to Jan 2014, we identified CRC patients who underwent (18)F-FDG-PET before starting any neoadjuvant treatments and surgery. Radiomics features were extracted from the primary lesions identified on (18)F-FDG-PET. Patients were divided into a training and validation set by random sampling. A least absolute shrinkage and selection operator Cox regression model was applied for prognostic signature building with progression-free survival (PFS) using the training set. Using the calculated radiomics score, a nomogram was developed, and its clinical utility was assessed in the validation set. A total of 381 patients with surgically resected CRC patients (training set: 228 vs. validation set: 153) were included. In the training set, a radiomics signature labeled as a rad_score was generated using two PET-derived features, such as gray-level run length matrix long-run emphasis (GLRLM_LRE) and gray-level zone length matrix short-zone low-gray-level emphasis (GLZLM_SZLGE). Patients with a high rad_score in the training and validation set had a shorter PFS. Multivariable analysis revealed that the rad_score was an independent prognostic factor in both training and validation sets. A radiomics nomogram, developed using rad_score, nodal stage, and lymphovascular invasion, showed good performance in the calibration curve and comparable predictive power with the staging system in the validation set. Textural features derived from (18)F-FDG-PET images may enable detailed stratification of prognosis in patients with CRC. MDPI 2021-01-21 /pmc/articles/PMC7866240/ /pubmed/33494345 http://dx.doi.org/10.3390/cancers13030392 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kang, Jeonghyun Lee, Jae-Hoon Lee, Hye Sun Cho, Eun-Suk Park, Eun Jung Baik, Seung Hyuk Lee, Kang Young Park, Chihyun Yeu, Yunku Clemenceau, Jean R. Park, Sunho Xu, Hongming Hong, Changjin Hwang, Tae Hyun Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer |
title | Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer |
title_full | Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer |
title_fullStr | Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer |
title_full_unstemmed | Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer |
title_short | Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer |
title_sort | radiomics features of (18)f-fluorodeoxyglucose positron-emission tomography as a novel prognostic signature in colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866240/ https://www.ncbi.nlm.nih.gov/pubmed/33494345 http://dx.doi.org/10.3390/cancers13030392 |
work_keys_str_mv | AT kangjeonghyun radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT leejaehoon radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT leehyesun radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT choeunsuk radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT parkeunjung radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT baikseunghyuk radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT leekangyoung radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT parkchihyun radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT yeuyunku radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT clemenceaujeanr radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT parksunho radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT xuhongming radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT hongchangjin radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer AT hwangtaehyun radiomicsfeaturesof18ffluorodeoxyglucosepositronemissiontomographyasanovelprognosticsignatureincolorectalcancer |